STAGE IVB SINONASAL CANCER AJCC V8
Clinical trials for STAGE IVB SINONASAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB SINONASAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB SINONASAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on tough head & neck cancers
Disease control Not yet recruitingThis early-stage trial is testing whether a new drug called camonsertib, combined with a precise form of radiation therapy, can help control head and neck cancers that have returned or cannot be surgically removed. The main goals are to find the safest dose of the drug-radiation …
Matched conditions: STAGE IVB SINONASAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New combo therapy aims to shrink tumors, save organs in rare head cancer
Disease control Not yet recruitingThis study is testing if adding a new immunotherapy drug called cemiplimab to standard chemotherapy before surgery works better than chemotherapy alone for advanced sinonasal squamous cell carcinoma, a rare cancer in the nasal cavity and sinuses. The goal is to see if the combina…
Matched conditions: STAGE IVB SINONASAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Feb 23, 2026 14:53 UTC